English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/177728
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Diagnostic value of circulating miRNAs: association with the presence and extension of coronary atherosclerosis in patients with suspected ischemic heart disease

AuthorsGonzalo-Calvo, David de; Sanchez Vega, J.; Vilades, David; Nasarre, Laura; Leta, Rubén; Carreras, Francesc; Llorente-Cortés, Vicenta
Issue Date23-Apr-2017
Citation85th EAS Congress (2017)
Abstract[Aim] Circulating miRNAs have been proposed as biomarkers of ischemic heart disease (IHD). Nonetheless, most studies are based on small case-control approaches, with inadequate consideration of comorbidities and medications, and no comparison with established biomarkers. We have previously demonstrated the potential of miR-24-3p and miR-130a-3p as indicators of coronary atherosclerosis. Here, we determined the diagnostic value of both miRNAs in a real-world cohort of patients with suspected IHD.
[Methods] Plasma samples were collected from 105 consecutive patients referred for computed tomography angiography (CCTA) for evaluation of suspected IHD. Presence and extension of coronary atherosclerosis were evaluated as previously described. Circulating miRNAs were analyzed using RT-qPCR.
[Results] Circulating levels of miR-130a-3p were significantly reduced in patients with significant coronary stenosis (narrowing > 50 % of the reference luminal diameter) compared to patients without stenosis or non-significant stenosis (narrowing 1-49 % of the reference luminal diameter) (P < 0.050). No differences were observed for miR-24-3p or us-CRP. Circulating levels of miR-24-3p and miR-130a-3p were reduced in patients with higher extension of coronary atherosclerosis [segment involvement score (SIS) > 5] (P < 0.050). After adjustment for potential confounders (risk factors and medications), circulating miR-130a-3p levels were inversely associated with the extension of coronary atherosclerosis (P < 0.050 for all regression models). No association was observed with miR-24-3p or us-CRP. The addition of miR-130a-3p to a model of coronary atherosclerosis resulted in a higher area under the ROC curve.
[Conclusions] Circulating miR-130a-3p is a potential biomarker of coronary atherosclerosis in patients with clinically suspected of IHD.
URIhttp://hdl.handle.net/10261/177728
Appears in Collections:(IIBB) Comunicaciones congresos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.